Via activation of TGF-β and MAPK signal, SIX1 enhanced the accumulation of cancer stem cells (CSCs) as well as induced epithelial-mesenchymal transition (EMT), and even switched the role of TGF-β/SMAD signal from tumor suppressors to oncogenic proteins in breast cancer (13–16). Here, SIX1 is linked to breast carcinoma.